Fennec Pharmaceuticals Inc
TSX:FRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
TSX:FRX
|
US |
|
Cbrain A/S
F:C6F
|
DK |
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
N
|
North American Construction Group Ltd
XBER:N5Z
|
CA |
|
M
|
Marathon Petroleum Corp
XBER:MPN
|
US |
|
U
|
United Utilities Group PLC
DUS:UUEC
|
UK |
|
E
|
Evolus Inc
F:EVL
|
US |
|
Lineage Inc
NASDAQ:LINE
|
US |
|
T
|
Toll Brothers Inc
F:TLK
|
US |
Wall St Price Targets
FRX Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for FRX is 23.22 CAD with a low forecast of 19.2 CAD and a high forecast of 27.63 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FRX's stock price target?
Price Target
23.22
CAD
According to Wall Street analysts, the average 1-year price target for FRX is 23.22 CAD with a low forecast of 19.2 CAD and a high forecast of 27.63 CAD.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
48%
The compound annual growth rate for Revenue over the next 3 years is 48%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
46%
The compound annual growth rate for Gross Profit over the next 3 years is 46%.
